REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., trading under the ticker PAIC, operates in the life sciences and biosciences sector and filed an 8-K current report with the SEC on June 24, 2026, under accession number 0001193125-26-281200. The filing signals a material corporate event reportable under Exchange Act obligations, consistent with post-combination disclosure activity common among SPAC-affiliated entities in the healthcare and biotechnology space. Revelation Biosciences represents one of many life sciences companies that have intersected with the SPAC market as sponsors and targets continue to navigate the evolving regulatory and capital environment. Sign up at SpacDesk for full filing history, sponsor data, and real-time alerts on PAIC and hundreds of other SPAC-related companies.